Is stem cell therapy for Diabetes (Type 1 & 2) covered by insurance?
Coverage depends on product, indication, country and policy. Obtain a written eligibility and coverage decision for the exact authorised treatment or trial, including immunosuppression, monitoring and complications; do not infer it from coverage of insulin.
The cost picture for Diabetes (Type 1 & 2)
Costs cannot be generalised across routine diabetes care, authorised islet transplantation and investigational cell products. Obtain an itemised estimate for assessment, product, procedure, immunosuppression where applicable, monitoring, travel and complication care. Do not interrupt insulin or other established treatment because an experimental programme is being considered.
Am I a candidate? → · Diabetes (Type 1 & 2): full overview → · Diabetes (Type 1 & 2) cost → · Cost →
Evidence checked against ISSCR, FDA and EMA guidance. See our editorial standards. This is information, not medical advice. Educational information, not medical advice; figures indicative.
Sources & further reading
More on this condition
- Diabetes (Type 1 & 2): cell-therapy evidence and registered trials
- How much does stem cell therapy for Diabetes (Type 1 & 2) cost? (2026)
- Diabetes (Type 1 & 2) stem cell therapy — your questions answered (2026)
- Diabetes (Type 1 & 2): cell-therapy evidence by therapy class
- MSC vs HSCT for Diabetes (Type 1 & 2): what the registries show